Carbohydrate restriction has gained increasing popularity as an adjunctive nutritional
therapy for diabetes management. However, controversy remains regarding the long-term …

Extensive research has demonstrated the efficacy of the LCD to improve the most robust
CVD risk factors, such as hyperglycemia, hypertension, and atherogenic dyslipidemia. Our …

Ketogenic dietary interventions (KDIs) are beneficial in animal models of autosomal-
dominant polycystic kidney disease (ADPKD). KETO-ADPKD, an exploratory, randomized …

Ketogenic metabolic therapy (KMT) is a medical nutrition therapy to address certain health
and disease conditions. It is increasingly used for many non-communicable diseases that …

Cardiovascular disease (CVD) is the most common cause of morbidity and mortality in
developed countries. The prevalence of CVD is much higher in patients with type 2 diabetes …

Background Type 2 diabetes (T2D) is often regarded as a progressive, lifelong disease
requiring an increasing number of drugs. Sustained remission of T2D is now well …

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited
cause of renal failure and has limited pharmacological treatment options. Disease …

Ketogenic diets have been widely used for weight loss and are increasingly used in the
management of type 2 diabetes. Despite evidence that ketones have multiple positive effects …

Objectives Because evidence linking carbohydrate consumption to diabetic nephropathy
(DN) is scarce, and the association between a low-carbohydrate diet (LCD) and DN has not …

Ketogenic (very low carbohydrate) diets have well-established, as well as potential, benefits
in the treatment of neurological disorders. Over a century ago the ketogenic diet was …